Alphabet's AI-drug development could be a big tailwind, says Big Technology’s Alex Kantrowitz

CNBC’s Deirdre Bosa, Big Technology’s Alex Kantrowitz and Wealth Enhancement’s Ayako Yoshioka, join 'Closing Bell' to discuss Alphabet ahead of its earnings